Skip to content

seqWell

2 viewers · 30d

Total raised

$3.1M

2 filings since 2024 · latest SAFE filed

Cumulative raised
LAST ROUND
SAFE · $12K
ROUNDS
2
INVESTORS
1
FOUNDED
N/A
HQ
Beverly, MA
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

seqWell Inc. is a biotechnology company dedicated to advancing the efficiency and accuracy of DNA/RNA library preparation workflows for next-generation sequencing (NGS). By pioneering innovative solutions, seqWell streamlines complex processes, making genetic testing more accessible and reliable for laboratories worldwide.

What sets it apart

seqWell stands out for its ability to condense multiple sequencing preparation steps into singular, efficient processes, significantly reducing preparation time and error rates in genetic testing workflows.

Funding history

2 rounds
SAFE+1Jan 15, 2025
Form D
+$12K$3.1M total
EquitySep 16, 2024
Form D
+$3.1M$3.1M total

Products

1 tracked

ExpressPlex™

Library Preparation Solution

ExpressPlex™ is a revolutionary product from seqWell that simplifies the traditional library preparation workflows for sequencing, integrating multiple procedural steps into a single streamlined process. This product enhances quality control measures and supports a wide range of sequencing applications with improved efficiency and reduced complexity.

  • Simplified library prep
  • Combines 3-4 steps into one process
  • Enhanced quality control
  • Versatile across various sequencing applications

Links

WebsiteSEC EDGAR filings